vs

Side-by-side financial comparison of Solventum (SOLV) and Texas Roadhouse, Inc. (TXRH). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× Texas Roadhouse, Inc.). Texas Roadhouse, Inc. runs the higher net margin — 5.8% vs 3.2%, a 2.7% gap on every dollar of revenue. On growth, Texas Roadhouse, Inc. posted the faster year-over-year revenue change (3.1% vs -3.7%). Over the past eight quarters, Texas Roadhouse, Inc.'s revenue compounded faster (12.8% CAGR vs -0.4%).

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

Texas Roadhouse is an American steakhouse chain that specializes in steaks in a Texan and Southwestern cuisine style. It is a subsidiary of Texas Roadhouse Inc, which has two other concepts and is headquartered in Louisville, Kentucky. As of August 2025, the chain operates about 800 locations in 49 U.S. states and 70 international locations in 11 countries.

SOLV vs TXRH — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.3× larger
SOLV
$2.0B
$1.5B
TXRH
Growing faster (revenue YoY)
TXRH
TXRH
+6.8% gap
TXRH
3.1%
-3.7%
SOLV
Higher net margin
TXRH
TXRH
2.7% more per $
TXRH
5.8%
3.2%
SOLV
Faster 2-yr revenue CAGR
TXRH
TXRH
Annualised
TXRH
12.8%
-0.4%
SOLV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SOLV
SOLV
TXRH
TXRH
Revenue
$2.0B
$1.5B
Net Profit
$63.0M
$86.7M
Gross Margin
51.4%
Operating Margin
6.3%
6.5%
Net Margin
3.2%
5.8%
Revenue YoY
-3.7%
3.1%
Net Profit YoY
103.2%
-26.9%
EPS (diluted)
$0.37
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SOLV
SOLV
TXRH
TXRH
Q4 25
$2.0B
$1.5B
Q3 25
$2.1B
$1.4B
Q2 25
$2.2B
$1.4B
Q1 25
$2.1B
Q4 24
$2.1B
$1.4B
Q3 24
$2.1B
$1.3B
Q2 24
$2.1B
$1.3B
Q1 24
$2.0B
$1.3B
Net Profit
SOLV
SOLV
TXRH
TXRH
Q4 25
$63.0M
$86.7M
Q3 25
$1.3B
$84.9M
Q2 25
$90.0M
$116.1M
Q1 25
$137.0M
Q4 24
$31.0M
$118.5M
Q3 24
$122.0M
$86.8M
Q2 24
$89.0M
$123.1M
Q1 24
$237.0M
$116.0M
Gross Margin
SOLV
SOLV
TXRH
TXRH
Q4 25
51.4%
Q3 25
54.2%
Q2 25
54.4%
Q1 25
53.8%
Q4 24
53.9%
Q3 24
56.0%
Q2 24
54.6%
Q1 24
58.1%
Operating Margin
SOLV
SOLV
TXRH
TXRH
Q4 25
6.3%
6.5%
Q3 25
80.6%
6.7%
Q2 25
9.9%
9.3%
Q1 25
7.3%
Q4 24
6.6%
9.6%
Q3 24
13.2%
8.0%
Q2 24
11.7%
10.6%
Q1 24
18.9%
10.1%
Net Margin
SOLV
SOLV
TXRH
TXRH
Q4 25
3.2%
5.8%
Q3 25
60.4%
5.9%
Q2 25
4.2%
8.0%
Q1 25
6.6%
Q4 24
1.5%
8.2%
Q3 24
5.9%
6.8%
Q2 24
4.3%
9.2%
Q1 24
11.8%
8.8%
EPS (diluted)
SOLV
SOLV
TXRH
TXRH
Q4 25
$0.37
$1.29
Q3 25
$7.22
$1.25
Q2 25
$0.51
$1.70
Q1 25
$0.78
Q4 24
$0.18
$1.73
Q3 24
$0.70
$1.26
Q2 24
$0.51
$1.79
Q1 24
$1.37
$1.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SOLV
SOLV
TXRH
TXRH
Cash + ST InvestmentsLiquidity on hand
$878.0M
$134.7M
Total DebtLower is stronger
$5.0B
Stockholders' EquityBook value
$5.0B
$1.5B
Total Assets
$14.3B
$3.5B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SOLV
SOLV
TXRH
TXRH
Q4 25
$878.0M
$134.7M
Q3 25
$1.6B
$108.2M
Q2 25
$492.0M
$221.1M
Q1 25
$534.0M
Q4 24
$762.0M
$245.2M
Q3 24
$772.0M
$189.2M
Q2 24
$897.0M
$197.5M
Q1 24
$996.0M
$213.4M
Total Debt
SOLV
SOLV
TXRH
TXRH
Q4 25
$5.0B
Q3 25
$5.1B
Q2 25
$7.8B
Q1 25
$7.9B
Q4 24
$8.0B
Q3 24
$8.1B
Q2 24
$8.3B
Q1 24
$8.3B
Stockholders' Equity
SOLV
SOLV
TXRH
TXRH
Q4 25
$5.0B
$1.5B
Q3 25
$5.0B
$1.5B
Q2 25
$3.6B
$1.4B
Q1 25
$3.3B
Q4 24
$3.0B
$1.4B
Q3 24
$3.2B
$1.3B
Q2 24
$2.9B
$1.3B
Q1 24
$3.9B
$1.2B
Total Assets
SOLV
SOLV
TXRH
TXRH
Q4 25
$14.3B
$3.5B
Q3 25
$14.0B
$3.3B
Q2 25
$15.1B
$3.2B
Q1 25
$14.5B
Q4 24
$14.5B
$3.2B
Q3 24
$14.7B
$2.9B
Q2 24
$14.6B
$2.9B
Q1 24
$14.7B
$2.8B
Debt / Equity
SOLV
SOLV
TXRH
TXRH
Q4 25
1.00×
Q3 25
1.03×
Q2 25
2.14×
Q1 25
2.43×
Q4 24
2.71×
Q3 24
2.54×
Q2 24
2.90×
Q1 24
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SOLV
SOLV
TXRH
TXRH
Operating Cash FlowLast quarter
$95.0M
Free Cash FlowOCF − Capex
$32.0M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SOLV
SOLV
TXRH
TXRH
Q4 25
$95.0M
Q3 25
$76.0M
$143.6M
Q2 25
$169.0M
$237.7M
Q1 25
$29.0M
Q4 24
$219.0M
$237.5M
Q3 24
$169.0M
$138.7M
Q2 24
$355.0M
$133.9M
Q1 24
$442.0M
$243.4M
Free Cash Flow
SOLV
SOLV
TXRH
TXRH
Q4 25
$32.0M
Q3 25
$-21.0M
$14.7M
Q2 25
$59.0M
$160.4M
Q1 25
$-80.0M
Q4 24
$92.0M
$129.7M
Q3 24
$76.0M
$47.7M
Q2 24
$297.0M
$56.1M
Q1 24
$340.0M
$165.8M
FCF Margin
SOLV
SOLV
TXRH
TXRH
Q4 25
1.6%
Q3 25
-1.0%
1.0%
Q2 25
2.7%
11.1%
Q1 25
-3.9%
Q4 24
4.4%
9.0%
Q3 24
3.7%
3.7%
Q2 24
14.3%
4.2%
Q1 24
16.9%
12.5%
Capex Intensity
SOLV
SOLV
TXRH
TXRH
Q4 25
3.2%
Q3 25
4.6%
9.0%
Q2 25
5.1%
5.3%
Q1 25
5.3%
Q4 24
6.1%
7.5%
Q3 24
4.5%
7.2%
Q2 24
2.8%
5.8%
Q1 24
5.1%
5.9%
Cash Conversion
SOLV
SOLV
TXRH
TXRH
Q4 25
1.51×
Q3 25
0.06×
1.69×
Q2 25
1.88×
2.05×
Q1 25
0.21×
Q4 24
7.06×
2.00×
Q3 24
1.39×
1.60×
Q2 24
3.99×
1.09×
Q1 24
1.86×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

TXRH
TXRH

Food And Beverage$1.5B99%
Texas Roadhouse Segment$21.2M1%
Franchise$8.2M1%
Franchise Royalty$7.4M0%
Bubba S33Segment$2.3M0%

Related Comparisons